EUR 9.37
(-0.21%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 668.75 Million EUR | -12.9% |
2022 | 611.94 Million EUR | 12.44% |
2021 | 544.26 Million EUR | 3.8% |
2020 | 524.34 Million EUR | 4.54% |
2019 | 501.55 Million EUR | 3.89% |
2018 | 482.77 Million EUR | 7.24% |
2017 | 450.16 Million EUR | -10.79% |
2016 | 504.61 Million EUR | 21.76% |
2015 | 414.42 Million EUR | 402.3% |
2014 | 82.5 Million EUR | -85.17% |
2013 | 556.38 Million EUR | 23.46% |
2012 | 450.66 Million EUR | 2.79% |
2011 | 438.43 Million EUR | 11.9% |
2010 | 391.8 Million EUR | -2.49% |
2009 | 401.8 Million EUR | -27.93% |
2008 | 557.5 Million EUR | 21.76% |
2007 | 457.85 Million EUR | 5.72% |
2006 | 433.08 Million EUR | 13.52% |
2005 | 381.49 Million EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 168.89 Million EUR | 33.08% |
2024 Q1 | 174.1 Million EUR | 12.38% |
2023 Q1 | 163.4 Million EUR | -0.42% |
2023 Q3 | 129.92 Million EUR | -17.75% |
2023 FY | 533 Million EUR | -12.9% |
2023 Q4 | 154.91 Million EUR | 19.24% |
2023 Q2 | 157.96 Million EUR | -3.33% |
2022 Q2 | 153.3 Million EUR | -0.97% |
2022 Q1 | 154.8 Million EUR | -25.95% |
2022 FY | 611.94 Million EUR | 12.44% |
2022 Q4 | 164.08 Million EUR | 0.0% |
2021 Q1 | 112.8 Million EUR | -43.07% |
2021 Q3 | 72.44 Million EUR | -51.68% |
2021 Q2 | 149.95 Million EUR | 32.94% |
2021 FY | 544.26 Million EUR | 3.8% |
2021 Q4 | 209.06 Million EUR | 188.56% |
2020 Q2 | 139.18 Million EUR | 22.85% |
2020 Q3 | 73.71 Million EUR | -47.04% |
2020 FY | 524.34 Million EUR | 4.54% |
2020 Q4 | 198.14 Million EUR | 168.8% |
2020 Q1 | 113.3 Million EUR | -39.04% |
2019 FY | 501.55 Million EUR | 3.89% |
2019 Q4 | 185.85 Million EUR | 166.38% |
2019 Q2 | 129.32 Million EUR | 10.92% |
2019 Q3 | 69.77 Million EUR | -46.05% |
2019 Q1 | 116.6 Million EUR | -41.01% |
2018 Q1 | 92.7 Million EUR | -42.48% |
2018 FY | 482.77 Million EUR | 7.24% |
2018 Q2 | 126.55 Million EUR | 36.52% |
2018 Q4 | 197.67 Million EUR | 200.22% |
2018 Q3 | 65.84 Million EUR | -47.97% |
2017 Q4 | 161.16 Million EUR | 97.03% |
2017 FY | 450.16 Million EUR | -10.79% |
2017 Q2 | 149.06 Million EUR | 72.33% |
2017 Q3 | 81.8 Million EUR | -45.13% |
2017 Q1 | 86.5 Million EUR | -58.42% |
2016 Q4 | 208.01 Million EUR | 111.18% |
2016 FY | 504.61 Million EUR | 21.76% |
2016 Q1 | 97.9 Million EUR | -42.65% |
2016 Q3 | 98.5 Million EUR | -24.96% |
2016 Q2 | 131.25 Million EUR | 34.07% |
2015 Q4 | 170.72 Million EUR | 319.5% |
2015 Q3 | 40.69 Million EUR | -68.98% |
2015 Q2 | 131.2 Million EUR | 82.74% |
2015 FY | 414.42 Million EUR | 402.3% |
2015 Q1 | 71.8 Million EUR | 123.6% |
2014 Q1 | 127.3 Million EUR | -43.94% |
2014 FY | 82.5 Million EUR | -85.17% |
2014 Q4 | -304.19 Million EUR | -343.94% |
2014 Q3 | 124.7 Million EUR | -24.27% |
2014 Q2 | 164.66 Million EUR | 29.36% |
2013 Q3 | 110.1 Million EUR | -31.17% |
2013 FY | 556.38 Million EUR | 23.46% |
2013 Q1 | 106.5 Million EUR | 4403.17% |
2013 Q4 | 227.08 Million EUR | 106.26% |
2013 Q2 | 159.96 Million EUR | 50.2% |
2012 Q3 | 6.5 Million EUR | -95.06% |
2012 Q1 | 109.1 Million EUR | -35.26% |
2012 FY | 450.66 Million EUR | 2.79% |
2012 Q2 | 131.46 Million EUR | 20.5% |
2012 Q4 | 2.36 Million EUR | -63.62% |
2011 Q2 | 92.8 Million EUR | -2.32% |
2011 Q1 | 95 Million EUR | -21.88% |
2011 Q3 | 82.1 Million EUR | -11.53% |
2011 Q4 | 168.53 Million EUR | 105.27% |
2011 FY | 438.43 Million EUR | 11.9% |
2010 Q4 | 121.6 Million EUR | 47.39% |
2010 FY | 391.8 Million EUR | -2.49% |
2010 Q1 | 91.9 Million EUR | -23.99% |
2010 Q2 | 95.8 Million EUR | 4.24% |
2010 Q3 | 82.5 Million EUR | -13.88% |
2009 Q4 | 120.9 Million EUR | 55.2% |
2009 Q1 | 98.2 Million EUR | 0.0% |
2009 FY | 401.8 Million EUR | -27.93% |
2009 Q3 | 77.9 Million EUR | -25.67% |
2009 Q2 | 104.8 Million EUR | 6.72% |
2008 FY | 557.5 Million EUR | 21.76% |
2007 FY | 457.85 Million EUR | 5.72% |
2006 FY | 433.08 Million EUR | 13.52% |
2005 FY | 381.49 Million EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Faes Farma, S.A. | 127.02 Million EUR | -426.462% |
Laboratorio Reig Jofre, S.A. | 73.18 Million EUR | -813.811% |